

Profilin as a Novel Biomarker for Assessing Atherosclerosis in Hemodialysis Patients
https://doi.org/10.18087/cardio.2025.5.n2605
Abstract
Aim. Studies have shown a significant correlation between atherosclerosis and profilin-1. However, there is no information in the literature on the concentration of profilin in hemodialysis (HD) patients. This research examined the association between profilin-1 and carotid intima-media thickness (CIMT), as a marker of early atherosclerosis in HD patients.
Material and methods. 50 chronic HD patients and 38 healthy, control patients were included in this study. CIMT was measured by high-resolution ultrasonography.
Results. The HD patients were older and had higher concentrations of profilin-1, C reactive protein (CRP), uric acid, parathormone, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) than the control patients. In the HD patients, variables impacting CIMT were examined. CIMT and profilin-1 were significantly correlated (r = 0.637, p <0.01), as were CIMT and age (r = 0.424, p = 0.002). Linear regression analysis revealed that profilin-1 is a significant and independent predictor of carotid intima-media thickness (CIMT). Higher profilin-1 levels were associated with increased CIMT values.
Conclusion. For the first time, it has been shown that HD patients had greater concentrations of profilin-1 than healthy controls. Also, an independent relationship between profilin-1 and CIMT in HD patients was demonstrated.
About the Authors
Aydın GüçlüTurkey
Assoc. Prof., MD Department of Nephrology
Kırşehir, Turkey
Kağan Tur
Turkey
Assist. Prof., MD Department of Internal Medicine
Kırşehir, Turkey
Ömer Jaradat
Turkey
Attending Physician, MD Clinic of Emergency Medicine
Kırşehir, Turkey
Hacı Sütiçen
Turkey
Assist. Prof., MD
Kırşehir, Turkey
Muhammed Alpaslan
Turkey
Assist. Prof., MD Department of Radiology
Kırşehir, Turkey
Zeynel Erbesler
Turkey
Assoc. Prof., MD Department of Anesthesiology and Reanimation
Kırşehir, Turkey
Avşar Zerman
Turkey
Assist. Prof., MD. Department of Internal Medicine
Kırşehir, Turkey
References
1. Deo R, Dubin RF, Ren Y, Murthy AC, Wang J, Zheng H et al. Proteomic cardiovascular risk assessment in chronic kidney disease. European Heart Journal. 2023;44(23):2095–110. DOI: 10.1093/eurheartj/ehad115
2. Bevc S, Hojs R, Ekart R, Hojs-Fabjan T. Atherosclerosis in hemodialysis patients: traditional and nontraditional risk factors. Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica. 2006;15(4):151–7. PMID: 17982607
3. Choi Y, Jacobs DR, Kramer HJ, Shroff GR, Chang AR, Duprez DA. Nontraditional Risk Factors for Progression Through Chronic Kidney Disease Risk Categories: The Coronary Artery Risk Development in Young Adults Study. The American Journal of Medicine. 2023;136(4):380-389.e10. DOI: 10.1016/j.amjmed.2022.12.001
4. Lohraseb I, McCarthy P, Secker G, Marchant C, Wu J, Ali N et al. Global ubiquitinome profiling identifies NEDD4 as a regulator of Profilin 1 and actin remodelling in neural crest cells. Nature Communications. 2022;13(1):2018. DOI: 10.1038/s41467-022-29660-3
5. Read T-A, Cisterna BA, Skruber K, Ahmadieh S, Lindamood HL, Vitriol JA et al. The actin binding protein profilin 1 is critical for mitochondria function. bioRxiv. 2023. [Av. at: https://www.biorxiv.org/content/10.1101/2023.08.07.552354v4]
6. Paszek E, Zajdel W, Rajs T, Żmudka K, Legutko J, Kleczyński P. Profilin 1 and Mitochondria—Partners in the Pathogenesis of Coronary Artery Disease? International Journal of Molecular Sciences. 2021;22(3):1100. DOI: 10.3390/ijms22031100
7. Allen A, Gau D, Roy P. The role of profilin-1 in cardiovascular diseases. Journal of Cell Science. 2021;134(9):jcs249060. DOI: 10.1242/jcs.249060
8. Nezu T, Hosomi N, Aoki S, Matsumoto M. Carotid Intima-Media Thickness for Atherosclerosis. Journal of Atherosclerosis and Thrombosis. 2016;23(1):18–31. DOI: 10.5551/jat.31989
9. Spence JD. Assessment of atherosclerosis: should coronary calcium score and intima-media thickness be replaced by ultrasound measurement of carotid plaque burden and vessel wall volume? Current Opinion in Lipidology. 2023;34(3):126–32. DOI: 10.1097/MOL.0000000000000880
10. Mukherjee R, Bhattacharya R, Naiya SB, Mondal SS, Lyngdoh L. Assessment of Atherosclerosis in Sle Patients by Measuring Carotid Intima Media Thickness: A Cross Sectional Study. The Journal of the Association of Physicians of India. 2022;70(4):11–2. PMID: 35443433
11. Zhu X, Jing R, Li X, Zhang W, Tang Y, Liu T. Left ventricular hypertrophy, carotid atherosclerosis, and cognitive impairment in peritoneal dialysis patients. BMC Cardiovascular Disorders. 2023;23(1):127. DOI: 10.1186/s12872-023-03130-0
12. Karaer Büberci R, Öztekin PS, Duranay M. The relationship between apelin and carotid intima media thickness, and the presence of plaque in dialysis patients. Seminars in Dialysis. 2022;35(4):337–42. DOI: 10.1111/sdi.13052
13. Vlad C, Burlacu A, Florea L, Artene B, Badarau S, Covic A et al. A comprehensive review on apolipoproteins as nontraditional cardiovascular risk factors in end-stage renal disease: current evidence and perspectives. International Urology and Nephrology. 2019;51(7):1173–89. DOI: 10.1007/s11255-019-02170-w
14. Caglayan E, Romeo GR, Kappert K, Odenthal M, Südkamp M, Body SC et al. Profilin-1 Is Expressed in Human Atherosclerotic Plaques and Induces Atherogenic Effects on Vascular Smooth Muscle Cells. PLoS ONE. 2010;5(10):e13608. DOI: 10.1371/journal. pone.0013608
15. An M-H, Choi S-M, Lee P-H, Park S, Baek AR, Jang A-S. Cofilin-1 and profilin-1 expression in lung microvascular endothelial cells exposed to titanium dioxide nanoparticles. Advances in Clinical and Experimental Medicine. 2022;31(11):1255–64. DOI: 10.17219/acem/152032
16. Gau D, Daoud A, Allen A, Joy M, Sagan A, Lee S et al. Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer. Journal of Biological Chemistry. 2023;299(8):105044. DOI: 10.1016/j.jbc.2023.105044
17. Ding H, Chen B, Lu Q, Wang J. Profilin-1 mediates microvascular endothelial dysfunction in diabetic retinopathy through HIF-1α-dependent pathway. International Journal of Clinical and Experimental Pathology. 2018;11(3):1247–55. PMID: 31938219
18. Ramaiola I, Padró T, Peña E, Juan-Babot O, Cubedo J, Martin-Yuste V et al. Changes in thrombus composition and profilin-1 release in acute myocardial infarction. European Heart Journal. 2015;36(16):965–75. DOI: 10.1093/eurheartj/ehu356
19. Romeo GR, Moulton KS, Kazlauskas A. Attenuated Expression of Profilin-1 Confers Protection From Atherosclerosis in the LDL Receptor–Null Mouse. Circulation Research. 2007;101(4):357–67. DOI: 10.1161/CIRCRESAHA.107.151399
20. Eroglu E, Unal HU, Guclu A, Kocyigit I, Karaman M, Saglam M et al. The association of profilin‐1 levels with survival in chronic kidney disease. European Journal of Clinical Investigation. 2017;47(12):e12839. DOI: 10.1111/eci.12839
21. Diaz A, Bia D, Zócalo Y, Manterola H, Larrabide I, Lo Vercio L et al. Carotid Intima Media Thickness Reference Intervals for a Healthy Argentinean Population Aged 11–81 Years. International Journal of Hypertension. 2018;2018:1–13. DOI: 10.1155/2018/8086714
22. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid Atherosclerosis Measured by B-Mode Ultrasound in Populations: Associations with Cardiovascular Risk Factors in the ARIC Study. American Journal of Epidemiology. 1991;134(3):250–6. DOI: 10.1093/oxfordjournals.aje.a116078
Review
For citations:
Güçlü A., Tur K., Jaradat Ö., Sütiçen H., Alpaslan M., Erbesler Z., Zerman A. Profilin as a Novel Biomarker for Assessing Atherosclerosis in Hemodialysis Patients. Kardiologiia. 2025;65(5):16-20. https://doi.org/10.18087/cardio.2025.5.n2605